To robustly evaluate the hypothesis that thiamine functions as a natural PPARγ agonist and ameliorates T2D, we propose a three-tiered, integrated experimental strategy encompassing molecular, cellular, genetic, and in vivo investigations. Here, PPARG is linked to type 2 diabetes mellitus.